Karah Parschauer
2018
In 2018, Karah Parschauer earned a total compensation of $2M as General Counsel and Executive Vice President at Ultragenyx Pharmaceutical, a 42% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,940 |
|---|---|
| Option Awards | $1,078,095 |
| Salary | $386,251 |
| Stock Awards | $363,225 |
| Other | $32,819 |
| Total | $2,036,330 |
Parschauer received $1.1M in option awards, accounting for 53% of the total pay in 2018.
Parschauer also received $175.9K in non-equity incentive plan, $386.3K in salary, $363.2K in stock awards and $32.8K in other compensation.
Rankings
In 2018, Karah Parschauer's compensation ranked 5,644th out of 14,244 executives tracked by ExecPay. In other words, Parschauer earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,644 out of 14,244 | 60th |
Division Manufacturing | 2,133 out of 5,765 | 63rd |
Major group Chemicals And Allied Products | 787 out of 2,128 | 63rd |
Industry group Drugs | 657 out of 1,817 | 64th |
Industry Pharmaceutical Preparations | 507 out of 1,391 | 64th |
Source: SEC filing on April 22, 2019.
Parschauer's colleagues
We found six more compensation records of executives who worked with Karah Parschauer at Ultragenyx Pharmaceutical in 2018.
2018
Wladimir Hogenhuis
Ultragenyx Pharmaceutical
Chief Operating Officer
2018
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
2018
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2018
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2018
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officer and Executive Vice President
2018
John Pinion
Ultragenyx Pharmaceutical